Market Overview

EXCLUSIVE Valeant Update: Philidor Employee Confirms Company Owns R&O Pharmacy

Related VRX
Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech
The Anti-Price Gouging Lead Poisoning Treatment
Headline Risk Is Still Poison For These Stocks (GuruFocus)

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were down more than 25 percent following reports from Citron Research and SIRF that the company is engaged in questionable sales and accounting practices.

The crux of Citron Research's short thesis is that R&O Pharmacy, which filed for relief on a $69 million invoice from Valeant, is likely owned by Philidor Rx, a company Valeant has the right to purchase. If true, this raises concerns about Valeant's sales and inventory figures.

See Also: Valeant Denies Citron's 'Erroneous' Report; Analysts Also Cast Doubt

An employee of Philidor on Wednesday morning confirmed to Benzinga that R&O Pharmacy is owned by Philidor. Similarly, an employee of West Wilshire Pharmacy, a pharmacy that Citron raised concern about, confirmed to Benzinga that it is owned by Philidor.

On Wednesday afternoon, Valeant published a response to Citron's and SIRF's reports, but did not clarify the relationship with Philidor.

Posted-In: Citron Research Philidor R&O PharmacyNews Short Sellers Exclusives


Related Articles (VRX)

View Comments and Join the Discussion!